Skip to main content
. 2020 May 10;41(19):1810–1817. doi: 10.1093/eurheartj/ehaa373

Figure 2.

Figure 2

ACE2 concentrations in patients with and without use of an ACE inhibitor, ARB, and MRA (index and validation). ACEi, use of an angiotensin-converting enzyme (ACE) inhibitor; ARB, use of an angiotensin receptor blocker; MRA, use of a mineralocorticoid receptor antagonist.